DK0434625T3 - IGF-I til behandling af bivirkninger ved steroidterapi - Google Patents

IGF-I til behandling af bivirkninger ved steroidterapi

Info

Publication number
DK0434625T3
DK0434625T3 DK90810987.9T DK90810987T DK0434625T3 DK 0434625 T3 DK0434625 T3 DK 0434625T3 DK 90810987 T DK90810987 T DK 90810987T DK 0434625 T3 DK0434625 T3 DK 0434625T3
Authority
DK
Denmark
Prior art keywords
igf
treatment
side effects
steroid therapy
steroid
Prior art date
Application number
DK90810987.9T
Other languages
Danish (da)
English (en)
Inventor
Ronald L Goldberg
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of DK0434625T3 publication Critical patent/DK0434625T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK90810987.9T 1989-12-22 1990-12-13 IGF-I til behandling af bivirkninger ved steroidterapi DK0434625T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45521589A 1989-12-22 1989-12-22

Publications (1)

Publication Number Publication Date
DK0434625T3 true DK0434625T3 (da) 1995-06-26

Family

ID=23807878

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90810987.9T DK0434625T3 (da) 1989-12-22 1990-12-13 IGF-I til behandling af bivirkninger ved steroidterapi

Country Status (14)

Country Link
EP (1) EP0434625B1 (de)
JP (1) JP2934023B2 (de)
KR (1) KR100191381B1 (de)
AT (1) ATE121296T1 (de)
AU (1) AU641966B2 (de)
CA (1) CA2032859C (de)
DE (1) DE69018799T2 (de)
DK (1) DK0434625T3 (de)
ES (1) ES2071080T3 (de)
GR (1) GR3015900T3 (de)
IE (1) IE67510B1 (de)
IL (1) IL96711A (de)
NZ (1) NZ236614A (de)
ZA (1) ZA9010332B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128320A (en) * 1990-01-18 1992-07-07 Genentech, Inc. Method of restoring normal growth, weight gain or lean body mass in patients with glucocorticoid excess by administering igf-i
TW267102B (de) 1992-03-13 1996-01-01 Ciba Geigy
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
JPH10504971A (ja) * 1994-09-08 1998-05-19 カイロン コーポレイション インスリン様増殖因子の改善された生産方法
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
AU7271996A (en) * 1995-10-23 1997-05-15 Queen's University At Kingston Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and tgf-beta, optionally in combination with igf-1
CA2265972A1 (en) * 1996-09-16 1998-03-26 Philip D. Acott Use of igf-i for the treatment of polycystic kidney disease and related indications
US6015786A (en) 1997-02-25 2000-01-18 Celtrix Pharmaceuticals, Inc. Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US6514937B1 (en) 1997-02-25 2003-02-04 Celtrix Pharmaceuticals, Inc. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
AU3548999A (en) 1998-04-03 1999-10-25 Chiron Corporation Use of igfi for treating articular cartilage disorders
PT1141014E (pt) 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
WO2001087323A2 (en) 2000-05-16 2001-11-22 Genentech, Inc. Method for treating cartilage disorders
EP1917039A4 (de) 2005-08-01 2011-01-19 Genera Istrazivanja D O O Verfahren und zusammensetzungen zur regeneration von gelenkknorpel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60517B1 (en) * 1986-11-14 1994-07-27 Inst Molecular Biology Inc Wound healing and bone regeneration
SE8703625D0 (sv) * 1987-09-18 1987-09-18 Kabivitrum Ab New medical use
US4983581A (en) * 1988-05-20 1991-01-08 Institute Of Molecular Biology, Inc. Wound healing composition of IGF-I and TGF-β

Also Published As

Publication number Publication date
IE67510B1 (en) 1996-04-03
AU6824790A (en) 1991-06-27
AU641966B2 (en) 1993-10-07
CA2032859C (en) 2007-09-17
JPH04210648A (ja) 1992-07-31
ZA9010332B (en) 1991-08-28
EP0434625A3 (en) 1991-10-02
IL96711A0 (en) 1991-09-16
EP0434625A2 (de) 1991-06-26
GR3015900T3 (en) 1995-07-31
CA2032859A1 (en) 1991-06-23
IE904684A1 (en) 1991-07-17
KR100191381B1 (ko) 1999-06-15
IL96711A (en) 1996-01-19
KR910011279A (ko) 1991-08-07
NZ236614A (en) 1993-10-26
JP2934023B2 (ja) 1999-08-16
DE69018799D1 (de) 1995-05-24
ATE121296T1 (de) 1995-05-15
ES2071080T3 (es) 1995-06-16
DE69018799T2 (de) 1995-09-21
EP0434625B1 (de) 1995-04-19

Similar Documents

Publication Publication Date Title
DK0434625T3 (da) IGF-I til behandling af bivirkninger ved steroidterapi
DK0436469T3 (da) Præparat og fremgangsmåde til behandling af osteoporose i pattedyr
ES2113857T3 (es) Composiciones osteoinductoras.
DE69213231D1 (de) Zusammensetzung und methode zur verstärkung der sonnenbräunung
DK0659083T3 (da) Forebyggelse og behandling af perifer neuropati
DE69528058D1 (de) Bmp-9 zusammensetzungen
ATE109793T1 (de) Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung.
EE200000307A (et) Meetodid menopausijärgsete naiste raviks östrogeeni ülimadalate annustega
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
FI941133L (fi) Koostumus ja menetelmä hepatiitti C:n hoitamiseksi
EP0313305A3 (de) Chelatbildner enthaltende Lichtschutzmittel
DE60013266D1 (de) Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
DE69232205D1 (de) Haarbehandlungszusammensetzung
EA200200001A1 (ru) Способ повышения содержания флавоноидов и фенольных компонентов в растениях
ATE181549T1 (de) Verfahren zur herstellung von (s)-3-amino-1- substituiert-pirrolidine
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
EP0711159A4 (de) Verfahren und zusammensetzungen zur behandlung von asthma, arthereosklerose und entzuendlichen erkrankungen unter verwendung von optisch reinem (-)-zilenton
DK162880C (da) Fremgangsmaade til behandling af acycli hos faar og kvaeg, og anvendelse af gestagener og lh-rh eller dettes analoge ved behandling af acycli hos faar og kvaeg
ATE110961T1 (de) Behandlung von beatmungsabhängigkeit mit wachstumshormon.
DE69911955D1 (de) VERWENDUNG VON DANAZOL ZUR BEHANDLUNG VON HYPOGONADISMUS IN MÄNNERn
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
AU6937394A (en) Method for treating plant material in order to prevent the disadvantageous consequences of exposure to light